ScoreWhy is Alivus Life Sciences Ltd ?
1
High Management Efficiency with a high ROE of 19.43%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 6.24% and Operating profit at 5.36% over the last 5 years
4
Flat results in Jun 26
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 2.13 cr
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.38 times
5
With ROE of 17.5, it has a Fair valuation with a 4.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 13.11%, its profits have risen by 20.2% ; the PEG ratio of the company is 1.2
6
Majority shareholders : Promoters
7
Market Beating performance in long term as well as near term
- Along with generating 13.11% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Alivus Life should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Alivus Life for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Alivus Life
12.97%
0.49
26.65%
Sensex
-3.84%
-0.28
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.24%
EBIT Growth (5y)
5.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.92
Tax Ratio
24.87%
Dividend Payout Ratio
12.62%
Pledged Shares
0
Institutional Holding
12.72%
ROCE (avg)
31.22%
ROE (avg)
19.43%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
37
Price to Book Value
4.09
EV to EBIT
17.88
EV to EBITDA
16.19
EV to Capital Employed
4.95
EV to Sales
5.06
PEG Ratio
1.17
Dividend Yield
0.45%
ROCE (Latest)
27.70%
ROE (Latest)
17.52%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(Latest six months)
At Rs 322.74 cr has Grown at 22.52%
-2What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 2.13 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.38 times
Loading Valuation Snapshot...
Here's what is working for Alivus Life
Profit After Tax (PAT) - Latest six months
At Rs 322.74 cr has Grown at 22.52%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Alivus Life
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 2.13 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 2.38 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
